White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis - sprookjes - yvandenbroek - TriplyDB

White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis

White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis

http://www.wikidata.org/entity/Q37972980

about

Myelin damage and repair in pathologic CNS: challenges and prospects Cerebral hypoperfusion: a new pathophysiologic concept in multiple sclerosis?Sex differences and effects of estrogenic compounds on the expression of inflammatory molecules by astrocytes exposed to the insecticide dimethoate Sodium MRI of multiple sclerosis.Evaluation of Visual-Evoked Cerebral Metabolic Rate of Oxygen as a Diagnostic Marker in Multiple Sclerosis Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.Walking Speed and Brain Glucose Uptake are Uncoupled in Patients with Multiple Sclerosis Myelin Proteolipid Protein Complexes with αv Integrin and AMPA Receptors In Vivo and Regulates AMPA-Dependent Oligodendrocyte Progenitor Cell Migration through the Modulation of Cell-Surface GluR2 Expression.Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.Hypoxia diminishes the protective function of white-matter astrocytes in the developing brain OXPHOS mutations and neurodegeneration Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease.In vivo imaging reveals rapid astrocyte depletion and axon damage in a model of neuromyelitis optica-related pathology.Cerebral arterial bolus arrival time is prolonged in multiple sclerosis and associated with disability.Fluoxetine in progressive multiple sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial.Lactate Shuttles in Neuroenergetics-Homeostasis, Allostasis and Beyond.Astrocytic-Neuronal-Astrocytic Pathway Selection for Formation and Degradation of Glutamate/GABA Multiple sclerosis and pain.Myelination: do astrocytes play a role?Metabolic aspects of neuron-oligodendrocyte-astrocyte interactions.Neurotransmitter signaling in white matter.Mitochondrial dysfunction in central nervous system white matter disorders.Adapting brain metabolism to myelination and long-range signal transduction.Role of the Astrocytic Na(+), K(+)-ATPase in K(+) Homeostasis in Brain: K(+) Uptake, Signaling Pathways and Substrate Utilization.Resveratrol prevents ammonia-induced mitochondrial dysfunction and cellular redox imbalance in C6 astroglial cells.Neurodegeneration in multiple sclerosis and neuromyelitis optica.Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model.Vascular hypoperfusion in acute optic neuritis is a potentially new neurovascular model for demyelinating diseases.Tumor necrosis factor is elevated in progressive multiple sclerosis and causes excitotoxic neurodegeneration.Oxidative stress and mitochondrial dynamics malfunction are linked in Pelizaeus-Merzbacher disease.Associations of alcohol consumption with clinical and MRI measures in multiple sclerosis.Is impaired cerebral vasoreactivity an early marker of cognitive decline in multiple sclerosis patients?Cerebral white matter blood flow and energy metabolism in multiple sclerosis.Severe Convulsions and Dysmyelination in Both Jimpy and Cx32/47 -/- Mice may Associate Astrocytic L-Channel Function with Myelination and Oligodendrocytic Connexins with Internodal Kv Channels.Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice.Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.Adenosine Triphosphate Metabolism Measured by Phosphorus Magnetic Resonance Spectroscopy: A Potential Biomarker for Multiple Sclerosis Severity.Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis

P2860

Q26797407-6ABFAC26-4300-48BF-A9D7-BB0BE2D5CA1A Q27027921-6A4EB071-BBA3-480F-94DA-E7A4F35C4AD0 Q28570210-F61A3F0B-E4B8-4FD8-8C27-7D269638E516 Q30926519-FB92AB46-DDBE-4599-A6D6-FBC1C8412743 Q33831782-00F9CE6C-D795-481A-AF6F-062599901A78 Q34333921-0583F3DA-1D5A-475F-A589-17DFA9BFE691 Q35094371-1E49CEEC-813A-441D-99A1-111CD0A4A6AC Q35995980-C3D2C4A0-907C-4FF3-888F-7635BB44CFE9 Q36376697-8F84BE60-00F9-4DBB-A152-0C1626C173EB Q36403270-4200ED22-9434-4C9C-9C05-32D650F00BE8 Q36533623-2E29760B-498E-41B2-AE8A-FD0024844FCA Q36659440-8898BFE7-BD24-4A54-8483-8855F016C109 Q36724446-F2F93766-B9B7-4B1F-A2F9-3BB67F2C9DD4 Q37252524-A606C80C-E907-4812-BAD1-958E1CDB4D52 Q37459845-D1D80CD1-E483-4675-82FA-6F814FFEB3B8 Q37597918-685DE126-761C-42B1-A2F0-0013A6D0E8CB Q37620008-627FC7EC-D76F-4CE8-8CAA-555054351DDA Q37695357-06DE89DF-E526-4F22-8B72-DB50825E516D Q38036427-6F024A08-A138-487A-B266-DCDA91D23443 Q38058202-C09206A3-E4ED-48C5-B2DE-B1E9582A8662 Q38110285-2E9139D0-00C6-40D8-B4EA-BD58C2D3BDAB Q38206164-9D6AE08B-1BB6-41B5-B6FC-84A3BC7F4517 Q38215315-EE34051B-D99D-4F01-AD39-6A7149635053 Q38240551-DD018780-233D-4DBF-B582-D188AA413E10 Q38306209-1953C015-32A0-4AE8-BB58-F8A917AA2364 Q38717718-AB85EA67-4B7B-4808-93D2-543AD5C7F05A Q38965274-23C6E495-FB69-4A9F-B151-0EE831B5B1F6 Q40319080-6D93BB8A-D93F-4308-8D26-A457E03067EF Q41677192-3F3C962D-C893-4FDB-8410-B35AD1E31D4B Q44251663-8251024A-EE6F-4A3B-A8C4-9487C547B72D Q47658587-D890F152-6BE0-4115-A1E7-5146C3CE16BD Q47680564-FBDF80D5-7BA2-4714-9ED7-72D4F13C3C48 Q48021241-94E1D08E-0C29-45EE-9B59-D99FDCA50489 Q48154258-7D65EBF7-CACC-484A-8AF4-04878708171E Q48302520-2845CE1F-D7F6-4051-9231-0E746CCB4BF9 Q50239453-BCE837A9-B83E-46EA-B2E3-886900056EBE Q50906773-D53C9390-CF7B-4D0F-A42B-2DCD8EF596AE Q52096505-4B36295A-AF19-4121-AFB7-F8A3941F619E Q55088439-8664E76D-2761-4AD8-8CCE-8C2B22D30679 Q58775742-12F8BE0C-0503-43A6-B021-B7F351F4B6BF

P2860

White-matter astrocytes, axonal energy metabolism, and axonal degeneration in multiple sclerosis

http://www.wikidata.org/entity/Q37972980

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

White-matter astrocytes, axona ...... neration in multiple sclerosis

@en

White-matter astrocytes, axona ...... eration in multiple sclerosis.

@nl

type

label

White-matter astrocytes, axona ...... neration in multiple sclerosis

@en

White-matter astrocytes, axona ...... eration in multiple sclerosis.

@nl

prefLabel

White-matter astrocytes, axona ...... neration in multiple sclerosis

@en

White-matter astrocytes, axona ...... eration in multiple sclerosis.

@nl

P1433

Q37972980-0ABE946E-23E2-49D6-AB8F-FC3CB2951689

P1476

Q37972980-997E19E8-ECE1-4391-9BEC-9CCC3BBDD314

P2093

Q37972980-16978B49-121F-4662-A1EF-82B9E1E601FE

Q37972980-2471DAAA-BB47-44F6-BE79-FB39316E3C8E

Q37972980-9E41F60A-75AD-4026-80A3-346A2869117D

Q37972980-F2A4A21F-4BD9-406F-B627-FFCDC04158F1

Q37972980-FC6F5485-3B2B-4800-8B1D-0CF830893BEC

P2860

Q37972980-0338F6C3-5744-48EA-AC81-D9487C0EA62E

Q37972980-0FF341F5-2574-4575-9729-66CF5C3CF122

Q37972980-11F942F8-1C0A-470E-B4D4-6C9523993AD8

Q37972980-146F37C9-B10B-422D-B1D7-191858CA65BC

Q37972980-154EEB59-BCF0-4269-B296-6C27B5AE577D

Q37972980-1734E452-A2A3-4253-8D88-A67EA441DBE7

Q37972980-1AB98C21-3DE5-4C7B-BDD4-4C41E084400A

Q37972980-1E98AFB7-340B-4066-9A12-8A058B719E3C

Q37972980-216AAD93-DC58-42E2-9718-0B2106FA2780

Q37972980-2F0F6A38-90C6-4337-9E6E-BA5C3ABA8821

P304

Q37972980-599DBE0D-9679-46FD-A03F-C1DC1806D7D3

P31

Q37972980-43B241DF-2A36-448E-BDC5-103BAE0108A0

P356

Q37972980-EA224EC3-FB1C-4EA3-A933-A1C211505546

P433

Q37972980-461A9AF6-6B3B-4ADD-800C-2DFC30BA843F

P478

Q37972980-37CED04F-1E88-4E04-B603-7556FDECBF40

P50

Q37972980-7F577A41-A397-4232-96AE-8FD4D261B97C

P577

Q37972980-6871F03A-F5B6-4DB9-B879-203DB1E29025

P5875

Q37972980-CE30E1AC-9462-4B0B-A1BA-CC05B8BDB863

P698

Q37972980-7DED7D0A-40DC-4F16-BD37-C7D917668F39

P921

Q37972980-4DE80C32-8A29-457B-81C8-6280C1D4FC22

Q37972980-825c7780-7a8a-4b18-8538-25618a3ff75a

P932

Q37972980-3A4AA05D-8CD6-4ED4-916D-AD9A2CDA5985

P356

P1433

Journal of Cerebral Blood Flow & Metabolism

P1476

White-matter astrocytes, axona ...... neration in multiple sclerosis

@en

P2093

Guy Laureys

http://www.w3.org/2001/XMLSchema#string

Jan Debruyne

http://www.w3.org/2001/XMLSchema#string

Melissa Cambron

http://www.w3.org/2001/XMLSchema#string

Miguel D'Haeseleer

http://www.w3.org/2001/XMLSchema#string

Ralph Clinckers

http://www.w3.org/2001/XMLSchema#string

P2860

Neurotransmitter receptors in the life and death of oligodendrocytes

Astrocyte glutamate transport: review of properties, regulation, and physiological functions

Glutamate uptake

Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid

Synthesis of N-acetyl-L-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport

Increased expression and function of glutamate transporters in multiple sclerosis

Multiple sclerosis

Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla

Glutamate-induced losses of oligodendrocytes and neurons and activation of caspase-3 in the rat spinal cord

Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis

P304

413-424

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/JCBFM.2011.193

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Jacques De Keyser

P577

2012-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51979880

http://www.w3.org/2001/XMLSchema#string

P698

22214904

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

3293127

http://www.w3.org/2001/XMLSchema#string